Zugriffe | |
---|---|
Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 152 |
November 2023 | Dezember 2023 | Januar 2024 | Februar 2024 | März 2024 | April 2024 | Mai 2024 | |
---|---|---|---|---|---|---|---|
Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response | 2 | 1 | 1 | 1 | 1 | 4 | 0 |
Zugriffe | |
---|---|
2021_Yu_etal.pdf | 54 |